DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Raymond James Maintains Outperform on Alexion Pharmaceuticals, Lowers Price Target to $159

Raymond James maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and lowers the price target from $162 to $159.

Benzinga · 01/31/2020 12:50

Raymond James maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and lowers the price target from $162 to $159.